Preview — Barron's
Wednesday 4/10
The Bureau of Labor Statistics releases the consumer price index for March. Consensus estimate is for a 3.4% year-over-year increase, two-tenths of a percentage point more than in February. The core CPI, which excludes volatile food and energy prices, is expected to rise 3.7%, a tenth of a percentage point less than previously. CPI data have come in hotter than expected so far this year and, along with continued strength in the labor market, have caused bond yields to hit new highs for the year.
The Federal Open Market Committee releases the minutes from its mid-March monetary-policy meeting. At the meeting, the FOMC kept the federal-funds rate unchanged at 5.25% to 5.50%.
Thursday 4/11
The European Central Bank announces its monetary-policy decision. The ECB is widely expected to keep its key short-term interest rate unchanged at 4%. The ECB's next policy move will probably be a rate cut, with traders eyeing the June meeting.
Friday 4/12
First-quarter earnings season begins in earnest with the big banks announcing results. Citigroup, JPMorgan Chase, and Wells Fargo all report before the opening bell.
To subscribe to Barron's, visit http://www.barrons.com/subscribe
(END) Dow Jones Newswires
April 05, 2024 21:45 ET (01:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast